Related topics

Larimar: Q1 Earnings Snapshot

May 12, 2022 GMT

BALA CYNWYD, Pa. (AP) _ Larimar Therapeutics, Inc. (LRMR) on Thursday reported a loss of $8.9 million in its first quarter.

The Bala Cynwyd, Pennsylvania-based company said it had a loss of 49 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LRMR at